Reactivation of Silenced WT1 Transgene by Hypomethylating Agents - Implications for in vitro Modeling of Chemoimmunotherapy

por Kwon, Yong-Rim, Son, Min-Jung, Kim, Hye-Jung, Kim, Yoo-Jin
Publicado 2012

Enhanced differentiation of mesenchymal stromal cells by three-dimensional culture and azacitidine

por Bae, Yoo-Jin, Kwon, Yong-Rim, Kim, Hye Joung, Lee, Seok, Kim, Yoo-Jin
Publicado en Blood Res (2017)

Enhanced polo-like kinase 1 expression in myelodysplastic syndromes

por Min, Kyoung Il, Park, Silvia, Shin, Seung-Hwan, Kwon, Yong-Rim, Kim, Hye-Joung, Kim, Yoo Jin
Publicado en Blood Res (2019)

Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients

por Kim, Kyoung-Woon, Kim, Hye Joung, Kim, Bo-Mi, Kwon, Yong-Rim, Kim, Hae-Rim, Kim, Yoo-Jin
Publicado en Stem Cell Res Ther (2018)

Gene expression signatures associated with sensitivity to azacitidine in myelodysplastic syndromes

por Kim, Kyuryung, Park, Silvia, Choi, Hayoung, Kim, Hye Joung, Kwon, Yong-Rim, Ryu, Daeun, Kim, Myungshin, Kim, Tae-Min, Kim, Yoo-Jin
Publicado en Sci Rep (2020)

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells

por Kwon, Yong-Rim, Kim, Hye Joung, Sohn, Min-Jung, Lim, Ji-Young, Park, Kyung-Shin, Lee, Seok, Chung, Nack-Gyun, Jeong, Dae-Chul, Min, Chang-Ki, Kim, Yoo-Jin
Publicado en Exp Hematol Oncol (2020)

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome

por Jung, Seung-Hyun, Kim, Yoo-Jin, Yim, Seon-Hee, Kim, Hye-Jung, Kwon, Yong-Rim, Hur, Eun-Hye, Goo, Bon-Kwan, Choi, Yun-Suk, Lee, Sug Hyung, Chung, Yeun-Jun, Lee, Je-Hwan
Publicado en Oncotarget (2016)